FGAM
BNTX icon

Financial Gravity Asset Management’s BioNTech BNTX Stock Holding History

Financial Gravity Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5
Closed -$528 – 1562
2024
Q1 		$528 Buy
+5
New +$479 ﹤0.01% 1361
2023
Q3 		– Sell
-108
Closed -$123 – 1297
2023
Q2 		$123 Buy
+108
New +$12.1K ﹤0.01% 1269
2023
Q1 		– Sell
-150
Closed -$171 – 1191
2022
Q4 		$171 Buy
+150
New +$23.1K ﹤0.01% 1010

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Financial Gravity Asset Management's BNTX Position: Q2 2024 in Review

Financial Gravity Asset Management sold out of BioNTech (BNTX) in Q2 2024, closing a stake of 5 shares — an estimated $528 sold.

Financial Gravity Asset Management first reported a position in BNTX in Q4 2022 and held it in 3 quarters. The position peaked at $528 in Q1 2024. 286 funds tracked by Wall St. Rank hold BNTX as of Q2 2024.

  • Financial Gravity Asset Management reported no remaining BioNTech position as of Q2 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 5 BioNTech shares in Q2 2024, an estimated $528.
  • Financial Gravity Asset Management first reported a position in BioNTech in Q4 2022 and held it in 3 quarters.
  • Financial Gravity Asset Management's BioNTech position peaked at $528 in Q1 2024.
  • 286 funds tracked by Wall St. Rank held BioNTech as of Q2 2024.

Based on Financial Gravity Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.